Halozyme Therapeutics, Inc. (HALO): Price and Financial Metrics

HALO POWR Grades

• Quality is the dimension where HALO ranks best; there it ranks ahead of 83.12% of US stocks.
• The strongest trend for HALO is in Growth, which has been heading up over the past 177 days.
• HALO ranks lowest in Momentum; there it ranks in the 4th percentile.

HALO Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for HALO is 3.89 -- better than 87.34% of US stocks.
• HALO's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 602.19 -- higher than 95.25% of US-listed equities with positive expected earnings growth.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 8.11 for HALOZYME THERAPEUTICS INC; that's greater than it is for 86.73% of US stocks.
• Stocks that are quantitatively similar to HALO, based on their financial statements, market capitalization, and price volatility, are INFA, PRGS, BRKR, ACIW, and VERI.
• Visit HALO's SEC page to see the company's official filings. To visit the company's web site, go to www.halozyme.com.

HALO Valuation Summary

• HALO's price/sales ratio is 7.1; this is 273.68% higher than that of the median Healthcare stock.
• HALO's price/sales ratio has moved down 132.6 over the prior 232 months.

Below are key valuation metrics over time for HALO.

HALO Growth Metrics

The 5 year price growth rate now stands at 79.34%.
• The 5 year net income to common stockholders growth rate now stands at 30.98%.
• The 2 year cash and equivalents growth rate now stands at 12.36%.

Over the past 52 months, HALO's revenue has gone up $378,922,000.

The table below shows HALO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	660.116	240.11	202.129
2022-09-30	580.623	240.173	211.197
2022-06-30	487.477	292.277	366.15
2022-03-31	471.567	288.941	434.923
2021-12-31	443.31	299.44	402.71
2021-09-30	463.01	267.844	409.104

HALO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HALO has a Quality Grade of C, ranking ahead of 73.97% of graded US stocks.
• HALO's asset turnover comes in at 0.493 -- ranking 84th of 682 Pharmaceutical Products stocks.
• ARAV, XOMA, and MGNX are the stocks whose asset turnover ratios are most correlated with HALO.

The table below shows HALO's key quality metrics over time.